Hence, this study aimed to evaluate the expression of VISTA and TOX within venous tumor thrombus and primary ccRCC and to estimate their potency in predicting OS in this group of patients with RCC. This evidence concerns the gene VSIR and nonpapillary renal cell carcinoma.